Differential, Disease Modifying, Tractable: Identifying Optimal Drug Targets with Proteomics & AI

In this webinar, hosted by AAPS, we discuss how mass spectrometry-based discovery proteomics combined with AI-based target validation enables direct, deep interrogation of the proteome, across thousands of proteins in thousands of biosamples, for robust target discovery to identify and match differentially expressed, disease modifying, tractable protein targets with a drug to optimize its probability of success.